Biotricity, Inc. (BTCY)

Market Cap	12.87M
Revenue (ttm)	11.63M
Net Income (ttm)	-15.39M
Shares Out	9.26M
EPS (ttm)	-1.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84,241
Open	1.480
Previous Close	1.480
Day's Range	1.370 - 1.480
52-Week Range	0.480 - 3.784
Beta	1.54
Analysts	Hold
Price Target	n/a
Earnings Date	Feb 20, 2024

About BTCY

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, Cali...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Dr. Waqaas Al-Siddiq Ph.D.
• Employees: 55
• Stock Exchange: NASDAQ
• Ticker Symbol: BTCY

Financial Performance

In 2022, Biotricity's revenue was $9.64 million, an increase of 26.00% compared to the previous year's $7.65 million. Losses were -$19.53 million, -35.36% less than in 2021.